Paper21998254
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.
Pejchal R and 30 others. Science, 2011. Cited by 611 papers, by iCite.
Cite this record
ConductScience Library. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Papers, record 21998254. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21998254
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neutralizing | Major topic |
| HIV Antibodies | Major topic |
| HIV Envelope Protein gp120 | Major topic |
| HIV-1 | Major topic |
| Oligosaccharides | Major topic |
| Polysaccharides | Major topic |
| Antibody Specificity | |
| Binding Sites, Antibody | |
| Carbohydrate Conformation | |
| Cell Line | |
| Crystallography, X-Ray | |
| Disaccharides | |
| Epitopes | |
| Glycosylation | |
| Humans | |
| Hydrogen Bonding | |
| Immunoglobulin Fab Fragments | |
| Mannose | |
| Mannosides | |
| Models, Molecular | |
| Mutation | |
| Protein Conformation | |
| Protein Structure, Tertiary |
Source PubMed
Grants20
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Y1-GM-1104 | NIGMS NIH HHS | United States | PubMed | PubMed | |
| P41 RR017573 | NCRR NIH HHS | United States | P41RR017573 | PubMed and NIH | NIH RePORTER |
| P41 RR001209 | NCRR NIH HHS | United States | P41RR001209 | PubMed and NIH | NIH RePORTER |
| AI33292 | NIAID NIH HHS | United States | R01AI033292 | PubMed and NIH | NIH RePORTER |
| P01 AI082362 | NIAID NIH HHS | United States | P01AI082362 | PubMed and NIH | NIH RePORTER |
| F32 AI074372 | NIAID NIH HHS | United States | F32AI074372 | PubMed and NIH | NIH RePORTER |
| RR017573 | NCRR NIH HHS | United States | P41RR017573 | PubMed and NIH | NIH RePORTER |
| P41RR001209 | NCRR NIH HHS | United States | P41RR001209 | PubMed and NIH | NIH RePORTER |
| R01 AI084817 | NIAID NIH HHS | United States | R01AI084817 | PubMed and NIH | NIH RePORTER |
| HFE-224662 | CIHR | Canada | PubMed | PubMed | |
| R56 AI084817 | NIAID NIH HHS | United States | R01AI084817 | PubMed and NIH | NIH RePORTER |
| AI84817 | NIAID NIH HHS | United States | R01AI084817 | PubMed and NIH | NIH RePORTER |
| R37 AI033292 | NIAID NIH HHS | United States | R01AI033292 | PubMed and NIH | NIH RePORTER |
| AI74372 | NIAID NIH HHS | United States | F32AI074372 | PubMed and NIH | NIH RePORTER |
| R01 AI033292 | NIAID NIH HHS | United States | R01AI033292 | PubMed and NIH | NIH RePORTER |
| Y1-CO-1020 | NCI NIH HHS | United States | PubMed | PubMed | |
| AI082362 | NIAID NIH HHS | United States | P01AI082362 | PubMed and NIH | NIH RePORTER |
| U01 CA128416 | NCI NIH HHS | United States | U01CA128416 | PubMed and NIH | NIH RePORTER |
| R37AI033292 | NIH | NIH RePORTER | |||
| R56AI084817 | NIH | NIH RePORTER |
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12829775 | Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. | Science | 2003 | https://conductscience.org/library/papers/12829775 | PubMed |
| 2 | 21734041 | epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals. | J Virol | 2011 | https://conductscience.org/library/papers/21734041 | PubMed |
| 3 | 19374019 | DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. | J Struct Biol | 2009 | https://conductscience.org/library/papers/19374019 | PubMed |
| 4 | 8347567 | The molecular surface package. | J Mol Graph | 1993 | https://conductscience.org/library/papers/8347567 | PubMed |
| 5 | 12781660 | Accurate determination of local defocus and specimen tilt in electron microscopy. | J Struct Biol | 2003 | https://conductscience.org/library/papers/12781660 | PubMed |
| 6 | 10397822 | Kinetics of retrovirus production and decay. | Biotechnol Bioeng | 1999 | https://conductscience.org/library/papers/10397822 | PubMed |
| 7 | 15299374 | The CCP4 suite: programs for protein crystallography. | Acta Crystallogr D Biol Crystallogr | 1994 | https://conductscience.org/library/papers/15299374 | PubMed |
| 8 | 10089208 | A statistical analysis of N- and O-glycan linkage conformations from crystallographic data. | Glycobiology | 1999 | https://conductscience.org/library/papers/10089208 | PubMed |
| 9 | 7664102 | A Trojan horse with a sweet tooth. | Nat Struct Biol | 1995 | https://conductscience.org/library/papers/7664102 | PubMed |
| 10 | 16859925 | EMAN2: an extensible image processing suite for electron microscopy. | J Struct Biol | 2007 | https://conductscience.org/library/papers/16859925 | PubMed |
| 11 | 17395205 | Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. | J Mol Biol | 2007 | https://conductscience.org/library/papers/17395205 | PubMed |
| 12 | 19263523 | Appion: an integrated, database-driven pipeline to facilitate EM image processing. | J Struct Biol | 2009 | https://conductscience.org/library/papers/19263523 | PubMed |
| 13 | 10600563 | EMAN: semiautomated software for high-resolution single-particle reconstructions. | J Struct Biol | 1999 | https://conductscience.org/library/papers/10600563 | PubMed |
| 14 | 21709254 | Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21709254 | PubMed |
| 15 | 19922969 | Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. | Virology | 2010 | https://conductscience.org/library/papers/19922969 | PubMed |
| 16 | 21389135 | The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection. | J Virol | 2011 | https://conductscience.org/library/papers/21389135 | PubMed |
| 17 | 17825343 | Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. | Virology | 2007 | https://conductscience.org/library/papers/17825343 | PubMed |
| 18 | 20523901 | Few and far between: how HIV may be evading antibody avidity. | PLoS Pathog | 2010 | https://conductscience.org/library/papers/20523901 | PubMed |
| 19 | 15661147 | Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. | Virology | 2005 | https://conductscience.org/library/papers/15661147 | PubMed |
| 20 | 11861826 | Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. | J Virol | 2002 | https://conductscience.org/library/papers/11861826 | PubMed |
Cited by510
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 611 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931443 | Advances in HIV-1 Envelope-Based Vaccine Development. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931443 | PubMed |
| 42821509 | Targeting of conserved spike epitopes enables broad antibody neutralisation of diverse bat sarbecoviruses. | PLoS Biol | 2026 | https://conductscience.org/library/papers/42821509 | PubMed |
| 42812567 | Natural variations at the E433 site in Env-gp120 β20-β21 cooperate with V2 and gp41 mutations to modulate HIV-1 infectivity. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42812567 | PubMed |
| 42575882 | CAR T cell therapy beyond cancer: current status, challenges and future prospects. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42575882 | PubMed |
| 42247468 | HIV-1 BG505 SOSIP immunization induced B cell expansion targeting the 465-glycan hole, with neutralizing antibodies exhibiting distinct binding modes and mechanisms of virus inhibition. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42247468 | PubMed |
| 42207948 | Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection. | J Virol | 2026 | https://conductscience.org/library/papers/42207948 | PubMed |
| 42096521 | Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design. | Science | 2026 | https://conductscience.org/library/papers/42096521 | PubMed |
| 42057185 | Evaluating the utility of a nanoscale flow cytometer for detection of surface proteins on HIV and extracellular vesicles. | Virol J | 2026 | https://conductscience.org/library/papers/42057185 | PubMed |
| 41939861 | Immunomodulation by glycosylation: bridging glycobiology to adaptive immunity and therapeutic innovation. | Front Immunol | 2026 | https://conductscience.org/library/papers/41939861 | PubMed |
| 41910264 | Non-suppressible HIV viremia sustained by clonally expanded CD4+ T cells harboring a genomically defective provirus with an immune-evasive protein expression profile. | mBio | 2026 | https://conductscience.org/library/papers/41910264 | PubMed |
| 41796803 | Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41796803 | PubMed |
| 41778789 | Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation. | J Virol | 2026 | https://conductscience.org/library/papers/41778789 | PubMed |
| 41634487 | Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope. | Nat Immunol | 2026 | https://conductscience.org/library/papers/41634487 | PubMed |
| 41583464 | Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection. | Front Immunol | 2025 | https://conductscience.org/library/papers/41583464 | PubMed |
| 41547352 | A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41547352 | PubMed |
| 41318602 | GLYCO-BUILD: an enzymatic pipeline for the synthesis of peptides carrying eukaryotic N-glycans. | Nat Commun | 2025 | https://conductscience.org/library/papers/41318602 | PubMed |
| 41278942 | Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design. | bioRxiv | 2025 | https://conductscience.org/library/papers/41278942 | PubMed |
| 40964353 | Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope. | bioRxiv | 2025 | https://conductscience.org/library/papers/40964353 | PubMed |
| 40838752 | Parallel evolution of the elite neutralizer phenotype in divergent HIV-1 clades. | J Virol | 2025 | https://conductscience.org/library/papers/40838752 | PubMed |
| 40726783 | In Vitro Selection of Cyclized, Glycosylated Peptide Antigens That Tightly Bind HIV High Mannose Patch Antibodies. | ACS Cent Sci | 2025 | https://conductscience.org/library/papers/40726783 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| FANCB | 2187 | PubTator's text mining | https://conductscience.org/library/genes/2187 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
| MAN1A1 | 4121 | PubTator's text mining | https://conductscience.org/library/genes/4121 | NCBI Gene |
| MLC1 | 23209 | PubTator's text mining | https://conductscience.org/library/genes/23209 | NCBI Gene |
| SLCO2A1 | 6578 | PubTator's text mining | https://conductscience.org/library/genes/6578 | NCBI Gene |
Data3
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21998254
GET https://conductscience.org/api/papers/v1/21998254/authors?page=2